Gilead Sciences Stock Analysis (NASDAQ:GILD)
Gilead Sciences Analysis Video
View Gilead Sciences stock analysis video. This is our GILD analyst opinion covering the buy and sell arguments for GILD stock.
Gilead Sciences, Inc. Stock Rating (4.2/5)
Our Gilead Sciences stock opinion is based on fundamentals of the company. This Gilead Sciences stock analysis is based on latest Q4 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.
Should you buy GILD stock?
- The TTM operating margin was good at 58% for Gilead Sciences.
- Net margins stood at a healthy 44.4% (average) for Gilead Sciences in the Trailing Twelve Months.
- The price to earnings multiple of 6.1 is attractive when compared with the industry average PE ratio of 22.5.
- GILD stock is trading at a favorable price to sales multiple of 3 as against the Medical-Biomed-Genetics industry average multiple of 4.6.
- Gilead Sciences generates a high return on invested capital of 46.8%.
- Gilead Sciences has a good Return On Equity (ROE) of 78.5%.